Valeant Pharmaceuticals International (VRX)
Create an Alert
84.00
-0.20 -0.24%
NYSE
Jun 17, 5:00PM
BATS Real time
Currency in USD
Valeant Pharmaceuticals International Accounts Receivable:
1.054B for March 31, 2013Valeant Pharmaceuticals International Historical Accounts Receivable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 1.054B |
| Dec. 31, 2012 | 769.47M |
| Sept. 30, 2012 | 805.01M |
| June 30, 2012 | 611.20M |
| March 31, 2012 | 613.56M |
| Dec. 31, 2011 | 468.54M |
| Sept. 30, 2011 | 450.38M |
| June 30, 2011 | 411.55M |
| March 31, 2011 | 471.10M |
| Dec. 31, 2010 | 274.82M |
| Sept. 30, 2010 | 291.12M |
| June 30, 2010 | 114.41M |
| March 31, 2010 | 105.02M |
| Dec. 31, 2009 | 112.16M |
| Sept. 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | 82.79M |
| Dec. 31, 2008 | 90.05M |
| Sept. 30, 2008 | 99.80M |
| June 30, 2008 | 93.10M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Accounts Receivable
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
YCharts takes accounts receivable from the balance sheet of a company. It is reported net of allowance for bad debts.
Learn More
VRX Accounts Receivable Benchmarks
| Companies | |
|---|---|
| Actavis | 1.276B |
| Salix Pharmaceuticals | 111.52M |
| Mylan | 1.514B |
VRX Accounts Receivable Rankings
| Overall |
95th percentile 688 of 16773 |
| Sector |
96th percentile 53 of 1408 in Healthcare |
| Industry |
96th percentile 6 of 152 in Drug Manufacturers - Specialty & Generic |
VRX Accounts Receivable Range, Past 5 Years
| Minimum | 82.79M | Mar 2009 |
| Maximum | 1.054B | Mar 2013 |
| Average | 384.35M |
